Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

(High)

(Positive)

Rhea-AI Summary

Apyx Medical (NASDAQ:APYX) is returning to Miami Swim Week 2026 with its Body by Apyx runway showcase, featuring real Renuvion® patients and body contouring transformations. The company is highlighting AYON Body Contouring System, which integrates Renuvion, advanced liposuction modalities, infiltration, aspiration and electrocautery in one platform.

According to Apyx Medical, AYON offers precision, workflow efficiency and real-time LIFT Technology, while Renuvion and J-Plasma® are supported by more than 90 clinical documents and FDA-cleared indications in aesthetic and surgical markets.

News Market Reaction – APYX

-4.65%

2 alerts

-4.65% Session close to close

+9.1% Peak Tracked

$176.29M Market Cap

0.2x Rel. Volume

In the May 27 session, APYX declined 4.65%, reflecting a moderate negative market reaction. Argus tracked a peak move of +9.1% during that session. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Apyx Medical’s marketing push around its Renuvion and AYON platforms vi...

Analysis

This announcement highlights Apyx Medical’s marketing push around its Renuvion and AYON platforms via the Body by Apyx showcase at Miami Swim Week. The focus is on real patient transformations, integration of multiple liposuction modalities, and Renuvion’s tissue contraction capabilities, underpinned by more than 90 supporting clinical documents. In context of recent 510(k) expansion and raised 2026 revenue guidance, investors may watch how such branding efforts translate into procedure volumes, AYON adoption, and future clinical evidence.

Key Figures

Clinical evidence base: more than 90 clinical documents Technology ranking: #1 trusted body contouring technology

2 metrics

Clinical evidence base more than 90 clinical documents Documents supporting Renuvion and J-Plasma effectiveness

Technology ranking #1 trusted body contouring technology Renuvion position among plastic surgeons as stated

Historical Context

5 past events · Latest: May 21 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 21	Clinical data update	Positive	+12.1%	New peer-reviewed cellulite and skin laxity data using Avéli and Renuvion.
May 14	Clinical publication	Positive	+13.5%	Retrospective 113-patient study showing benefits of Renuvion with liposuction.
May 11	Regulatory clearance	Positive	+6.8%	Expanded FDA 510(k) clearance adding power liposuction to AYON.
May 7	Earnings results	Positive	+21.9%	Q1 2026 revenue growth, narrower losses, and raised 2026 guidance.
Apr 23	Earnings date notice	Neutral	-0.8%	Announcement of upcoming Q1 2026 earnings release and call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent clinical and earnings announcements with Renuvion and AYON have generally coincided with positive share price reactions, indicating the market has rewarded evidence-based and financial progress.

Recent Company History

Over the last few months, Apyx has highlighted multiple Renuvion- and AYON-related milestones. On May 7, 2026, Q1 results showed revenue of $12.5 million and raised 2026 guidance, with shares reacting positively. Subsequent clinical publications on May 14 and May 21 underscored higher satisfaction and cellulite improvements using Renuvion, again followed by gains. An expanded FDA 510(k) for AYON power liposuction on May 11 also saw a positive move. Today’s Miami Swim Week-focused announcement continues the theme of promoting AYON and Renuvion, but is more marketing-oriented than prior data or regulatory updates.

Key Terms

body contouring, ultrasound assisted liposuction, power assisted liposuction, electrocautery, +2 more

6 terms

body contouring medical

"The market continues to evolve as patients look for more comprehensive solutions..."

Body contouring describes surgical or non‑surgical procedures that change the shape or appearance of the body by removing, redistributing or tightening fat and skin—think sculpting a statue to improve proportions. For investors, it signals market demand for devices, treatments and services, potential regulatory approvals, and consumer spending trends that can affect revenues and growth prospects for medical device makers, clinics and cosmetic product companies.

ultrasound assisted liposuction medical

"AYON integrates Renuvion and multiple body contouring modalities including advanced ultrasound assisted liposuction..."

Ultrasound assisted liposuction is a cosmetic procedure that uses focused ultrasound energy to loosen and break up fat before it is removed by suction, like using vibrations to dislodge crumbs before vacuuming. Investors watch it because it drives demand for specialized medical devices, training and clinic upgrades, and can influence revenues, regulatory scrutiny and liability exposure for manufacturers and providers in the aesthetic medicine market.

power assisted liposuction medical

"multiple body contouring modalities including advanced ultrasound assisted liposuction, power assisted liposuction, infiltration..."

A surgical body-contouring technique that uses a powered, vibrating cannula to loosen and remove excess fat more quickly and with less surgeon effort than manual liposuction; think of it as a small jackhammer that breaks up fat so it can be suctioned away. It matters to investors because device makers, clinics, and insurers can be affected by demand, procedure pricing, complication rates, technology approvals, and maintenance or replacement sales tied to this equipment.

electrocautery medical

"including advanced ultrasound assisted liposuction, power assisted liposuction, infiltration, aspiration, and electrocautery..."

Electrocautery is a surgical technique and the related devices that use a controlled electric current to cut tissue and seal blood vessels, much like a hot knife that both slices and cauterizes to stop bleeding. Investors watch electrocautery because it drives demand for surgical instruments, impacts hospital procedure costs, product approvals, and safety records, and can influence revenue, regulatory risk, and medical liability for device makers and healthcare providers.

tissue contraction medical

"Renuvion's tissue contraction and electrosurgical capabilities, empowering surgeons..."

Tissue contraction is the process by which biological tissue shortens or tightens, often as cells pull together during healing, scarring, or in response to a medical device or therapy. Investors should care because contraction can indicate a treatment working (like closing a wound) or an unwanted side effect (like tightening around an implant), and it affects product safety, clinical outcomes, regulatory approval and market acceptance — think of tissue acting like a shrinking piece of fabric or a tightening rubber band.

electrosurgical medical

"Renuvion's tissue contraction and electrosurgical capabilities, empowering surgeons..."

Electrosurgical describes tools and procedures that use controlled electric current to cut, seal, or stop bleeding in body tissues during medical procedures, similar to using a heated knife or a precise spark instead of a scalpel. For investors, electrosurgical products matter because they drive sales, device adoption, regulatory reviews, and liability risk in the surgical devices market—factors that affect revenue, profit margins, and company valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/27/2026 - 09:51 AM

CLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion^® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.

Building on last year's momentum, Apyx Medical has expanded its vision, introducing AYON, the next generation body contouring system designed to bring together the technologies surgeons rely on most into one comprehensive platform. AYON integrates Renuvion and multiple body contouring modalities including advanced ultrasound assisted liposuction, power assisted liposuction, infiltration, aspiration, and electrocautery, giving surgeons the flexibility to customize treatments based on patient anatomy, procedural goals, and surgical preference while helping improve workflow efficiency and procedural consistency.

"Miami Swim Week gives us an opportunity to showcase what body contouring can look like today through real patients and real outcomes," said Regis Cain, Senior Director of Marketing at Apyx Medical. "The market continues to evolve as patients look for more comprehensive solutions and more natural, confidence-driven results. Body by Apyx is designed to bring that to life by putting real transformations on stage and highlighting the technologies helping surgeons meet the growing demand for body contouring procedures."

The event will feature real Renuvion^® patients walking the runway, celebrating their personal journeys and the confidence gained through advanced aesthetic procedures. This one-of-a-kind showcase brings authenticity to the forefront, reshaping beauty standards through real results and real stories, powered by Renuvion^®, the #1 trusted body contouring technology among plastic surgeons.

For more information about Body by Apyx and to follow the journey at Miami Swim Week, visit www.apyxmedical.com and follow @Apyxmedical and @renuvion on social media.

About AYON Body Contouring System™:

AYON is a groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates advanced fat removal technologies, Renuvion's tissue contraction and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. With advanced features like LIFT Technology for real-time adjustments and Renuvion for enhanced tissue contraction, AYON sets a new standard in surgical care, streamlining procedures and maximizing patient outcomes. Backed by Apyx Medical's expertise and evidence-based design, AYON delivers consistent, reliable performance and an unmatched return on investment. As the first of its kind, AYON is revolutionizing body contouring and shaping the future of aesthetic surgery.

About Apyx Medical Corporation:

Apyx Medical Corporation is a surgical aesthetics company with a passion for elevating people's lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion^® and the AYON Body Contouring System^™ in the cosmetic surgery market and J-Plasma^® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, electrosurgical capabilities and Renuvion for tissue contraction, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/body-by-apyx-takes-center-stage-at-miami-swim-week-showcasing-real-patient-transformations-and-confidence-on-the-runway-302783210.html

SOURCE Apyx Medical Corporation

FAQ

What is Body by Apyx at Miami Swim Week 2026 for Apyx Medical (NASDAQ:APYX)?

Body by Apyx at Miami Swim Week 2026 is a runway showcase featuring real Renuvion® patients and body contouring transformations. According to Apyx Medical, it highlights authentic aesthetic results, patient confidence, and the company’s body contouring technologies in a high-visibility fashion event.

What is the AYON Body Contouring System highlighted by Apyx Medical (APYX)?

AYON Body Contouring System is an FDA-cleared, surgeon-designed platform combining fat removal, contouring and Renuvion tissue contraction. According to Apyx Medical, AYON integrates ultrasound-assisted and power-assisted liposuction, infiltration, aspiration and electrosurgical capabilities to streamline procedures, maximize workflow efficiency and support comprehensive body contouring treatments.

How does Renuvion technology from Apyx Medical (APYX) support body contouring procedures?

Renuvion provides helium plasma-based tissue contraction and controlled heat delivery for aesthetic and surgical applications. According to Apyx Medical, Renuvion enables surgeons to apply controlled energy to tissue, and its effectiveness is supported by more than 90 clinical documents across cosmetic and hospital surgical markets.

What makes Apyx Medical’s AYON and Renuvion platform unique for surgeons and patients?

AYON and Renuvion create an all-in-one, integrated body contouring solution for surgeons. According to Apyx Medical, the system combines fat removal, closed-loop contouring, electrosurgical functions and tissue contraction, aiming to deliver consistent performance, enhanced workflow efficiency and comprehensive treatment options tailored to individual patient anatomy and goals.

What clinical support and regulatory status back Apyx Medical’s Renuvion and AYON systems?

Renuvion and J-Plasma are supported by more than 90 clinical documents and have FDA-cleared indications. According to Apyx Medical, the AYON Body Contouring System is also FDA-cleared, reflecting evidence-based design and regulatory review for use in cosmetic body contouring procedures.

How can investors and patients follow Apyx Medical’s Body by Apyx campaign during Miami Swim Week 2026?

Investors and patients can follow Body by Apyx through Apyx Medical’s website and social media channels. According to Apyx Medical, updates and content are available at www.apyxmedical.com and via the @Apyxmedical and @renuvion accounts during Miami Swim Week.